AI
Allostery Investments Portfolio holdings
AUM
$7.85M
This Quarter Return
-2.75%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$69.3M
AUM Growth
+$18.4M
(+36%)
Cap. Flow
+$22.4M
Cap. Flow
% of AUM
32.32%
Top 10 Holdings %
Top 10 Hldgs %
65.25%
Holding
55
New
16
Increased
11
Reduced
5
Closed
5
Top Buys
| 1 |
Merus
MRUS
|
+$4.33M |
| 2 |
ABVX
Abivax
ABVX
|
+$3.18M |
| 3 |
BridgeBio Pharma
BBIO
|
+$2.77M |
| 4 |
SWTX
SpringWorks Therapeutics
SWTX
|
+$2.32M |
| 5 |
Beam Therapeutics
BEAM
|
+$1.81M |
Top Sells
| 1 |
Ionis Pharmaceuticals
IONS
|
+$905K |
| 2 |
MindMed
MNMD
|
+$905K |
| 3 |
Dianthus Therapeutics
DNTH
|
+$545K |
| 4 |
Crinetics Pharmaceuticals
CRNX
|
+$496K |
| 5 |
Jasper Therapeutics
JSPR
|
+$470K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ABVX
1
Abivax
ABVX
$6.35B
| $6.87M | 9.91% |
1,099,654
+508,401
| +86% | +$3.18M |
|
|
CNTA
2
Centessa Pharmaceuticals
CNTA
$2.92B
| $5.5M | 7.93% |
382,524
+98,007
| +34% | +$1.41M |
|
3
KalVista Pharmaceuticals
KALV
$708M
| $5.29M | 7.63% |
458,302
-20,798
| -4% | -$240K |
|
|
4
Merus
MRUS
$5.26B
| $5.25M | 7.57% |
124,657
+102,922
| +474% | +$4.33M |
|
5
Evolus
EOLS
$465M
| $4.97M | 7.16% |
412,754
-18,363
| -4% | -$221K |
|
6
Apogee Therapeutics
APGE
$2.2B
| $4.11M | 5.93% |
110,000
+10,000
| +10% | +$374K |
|
7
Alkermes
ALKS
$4.45B
| $3.8M | 5.48% |
115,000
-5,000
| -4% | -$165K |
|
|
JBIO
8
Jade Biosciences, Inc. Common Stock
JBIO
$251M
| $3.57M | 5.15% |
40,616
+16,311
| +67% | +$1.43M |
|
9
Zura Bio
ZURA
$130M
| $3M | 4.33% |
2,329,384
+814,258
| +54% | +$1.05M |
|
10
Arcellx
ACLX
$4.23B
| $2.89M | 4.16% |
44,000
+9,000
| +26% | +$590K |
|
11
Cytokinetics
CYTK
$6.12B
| $2.81M | 4.06% |
70,000
+5,000
| +8% | +$201K |
|
|
12
BridgeBio Pharma
BBIO
$9.79B
| $2.77M | 3.99% |
+80,000
| New | +$2.77M |
|
|
SWTX
13
DELISTED
SpringWorks Therapeutics
SWTX
| $2.32M | 3.34% |
+52,500
| New | +$2.32M |
|
|
14
Beam Therapeutics
BEAM
$2.08B
| $1.81M | 2.61% |
+92,754
| New | +$1.81M |
|
15
Soleno Therapeutics
SLNO
$2.85B
| $1.43M | 2.06% |
+20,000
| New | +$1.43M |
|
16
Vaxcyte
PCVX
$4.18B
| $1.21M | 1.74% |
+32,000
| New | +$1.21M |
|
|
17
Ionis Pharmaceuticals
IONS
$10.1B
| $1.06M | 1.52% |
35,000
-30,000
| -46% | -$905K |
|
18
Xenon Pharmaceuticals
XENE
$2.79B
| $1.01M | 1.45% |
30,000
| – | – |
|
19
Amylyx Pharmaceuticals
AMLX
$1.24B
| $942K | 1.36% |
+266,099
| New | +$942K |
|
20
Avalo Therapeutics
AVTX
$140M
| $858K | 1.24% |
107,141
+33,827
| +46% | +$271K |
|
|
VRNA
21
Verona Pharma
VRNA
$9.21B
| $794K | 1.14% |
+12,500
| New | +$794K |
|
22
Insmed
INSM
$30.8B
| $763K | 1.1% |
10,000
| – | – |
|
23
Akero Therapeutics
AKRO
$3.48B
| $729K | 1.05% |
+18,000
| New | +$729K |
|
24
Tarsus Pharmaceuticals
TARS
$2.08B
| $699K | 1.01% |
13,600
| – | – |
|
25
Gossamer Bio
GOSS
$787M
| $674K | 0.97% |
613,028
| – | – |
|